MedTrace Logo

Screening for Bleeding Disorders in Children

NCT05214300 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 96

Last updated 2022-01-28

No results posted yet for this study

Summary

The investigators try to improve the screening of bleeding disorders in children by identifying symptoms, laboratory abnormalities and clinical scores discriminating patients congenital bleeding disorders in order to create a simple screening algorithm applicable in pediatrics, aiming for use in pre-anesthetic consultation and in consultation by pediatricians and general practitioners.

Conditions

  • Bleeding Disorder

Sponsors & Collaborators

  • University Hospital, Montpellier

    lead OTHER

Principal Investigators

  • Alexandre THERON · University Hospital, Montpellier

Eligibility

Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-01
Primary Completion
2021-12-01
Completion
2021-12-20

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05214300 on ClinicalTrials.gov